1. Li Y, Chen J, Chen XG, et al.: Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514–523, 2002
2. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS: Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 183: 355–366, 2003
3. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD: I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136: 161–169, 2005
4. Horita Y, Honmou O, Harada K, Houkin K, Hamada H and Kocsis JD: Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84: 1495–1504, 2006
5. Liu H, Honmou O, Harada K, et al.: Neuroprotection by PIGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129: 2734–2745, 2006
6. Ukai R, Honmou O, Harada K, Houkin K, Hamada H and Kocsis JD: Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 24: 508–520, 2007
7. Sasaki M, Honmou O, Kocsis JD: A rat middle cerebral artery occlusion model and intravenous cellular delivery. Methods Mol Biol 549: 187–195, 2009
8. Toyama K, Honmou O, Harada K, et al.: Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol 216: 47–55, 2009
9. Sasaki M, Honmou O, Radtke C, Kocsis JD: Development of a middle cerebral artery occlusion model in the nonhuman primate and a safety study of i.v. infusion of human mesenchymal stem cells. PLoS One 6: e26577, 2011
10. Bang OY, Lee JS, Lee PH, Lee G: Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57: 874–882, 2005
11. Honmou O, Onodera R, Sasaki M, Waxman SG and Kocsis JD: Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med 18: 292–297, 2012
12. Chopp M, Li Y: Treatment of neural injury with marrow stromal cells. Lancet Neurol 1: 92–100, 2002
13. Chen J, Li Y, Zhang R, et al.: Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 1005: 21–28, 2004
14. Bunnell BA, Betancourt AM, Sullivan DE: New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther 1: 34, 2010
15. Gutiérrez-Fernández M, Rodríguez-Frutos B, Alvarez-Grech J, et al.: Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience 175: 394–405, 2011
16. Young HE, Steele TA, Bray RA, et al.: Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 264: 51–62, 2001
17. Zuk PA, Zhu M, Ashjian P, et al.: Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279–4295, 2002
18. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al.: Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338–1345, 2004
19. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294–1301, 2006
20. Sakai K, Yamamoto A, Matsubara K, et al.: Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J Clin Invest 122: 80–90, 2012
21. Song M, Lee JH, Bae J, Bu Y, Kim EC: Human dental pulp stem cells are more effective than human bone marrow-derived mesenchymal stem cells in cerebral ischemic injury. Cell Transplant 26: 1001–1016, 2017
22. Zhang X, Zhou Y, Li H, et al.: Intravenous administration of DPSCs and BDNF improves neurological performance in rats with focal cerebral ischemia. Int J Mol Med 41: 3185–3194, 2018
23. Shinagawa K, Mitsuhara T, Okazaki T, et al.: The characteristics of human cranial bone marrow mesenchymal stem cells. Neurosci Lett 606: 161–166, 2015
24. Abiko M, Mitsuhara T, Okazaki T, et al.: Rat cranial bone-derived mesenchymal stem cell transplantation promotes functional recovery in ischemic stroke model rats. Stem Cells Dev 27: 1053–1061, 2018
25. Ishizaka S, Horie N, Satoh K, Fukuda Y, Nishida N, Nagata I: Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44: 720–726, 2013
26. Kawabori M, Kuroda S, Ito M, et al: Timing and cell dose determine therapeutic effects of bone marrow stromal cell transplantation in rat model of cerebral infarct. Neuropathology 33: 140–148, 2013
27. Toyoshima A, Yasuhara T, Kameda M, et al.: Intra-Arterial Transplantation of Allogeneic Mesenchymal Stem Cells Mounts Neuroprotective Effects in a Transient Ischemic Stroke Model in Rats: Analyses of Therapeutic Time Window and Its Mechanisms. PLoS One 10: e0127302, 2015
28. Koizumi J, Yoshida Y, Nakazawa T, Ooneda G: Experimental studies of ischemic brain edema. 1: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 8: 1–8, 1986
29. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84–91, 1989
30. Neirinckx V, Agirman G, Coste C, et al.: Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Res Ther 6: 211, 2015
31. Pomiès P, Blaquière M, Maury J, Mercier J, Gouzi F, Hayot M: Involvement of the FoxO1/MuRF1/Atrogin-1 signaling pathway in the oxidative stress-induced atrophy of cultured chronic obstructive pulmonary disease myotubes. PLoS One 11: e0160092, 2016
32. Imura T, Tomiyasu M, Otsuru N, et al.: Hypoxic preconditioning increases the neuroprotective effects of mesenchymal stem cells in a rat model of spinal cord injury. J Stem Cell Res Ther 7: 375, 2017
33. Otsuka T, Imura T, Nakagawa K, et al.: Simulated microgravity culture enhances the neuroprotective effects of human cranial bone-derived mesenchymal stem cells in traumatic brain injury. Stem Cells Dev 27: 1287–1297, 2018
34. Lee YH, Saint-Jeannet JP: Sox9 function in craniofacial development and disease. Genesis 49: 200–208, 2011
35. Martens W, Wolfs E, Struys T, Politis C, Bronckaers A, Lambrichts I: Expression pattern of basal markers in human dental pulp stem cells and tissue. Cells Tissues Organs 196: 490-500, 2012
36. Chen X, Li Y, Wang L, et al.: Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22: 275–279, 2002
37. Huang W, Mo X, Qin C, Zheng J, Liang Z and Zhang C: Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Neurol Res 35: 320–328, 2013
38. Miki Y, Nonoguchi N, Ikeda N, Coffin RS, Kuroiwa T, Miyatake S: Vascular endothelial growth factor gene-transferred bone marrow stromal cells engineered with a herpes simplex virus type 1 vector can improve neurological deficits and reduce infarction volume in rat brain ischemia. Neurosurgery 61: 586– 594, 2007
39. Ikegame Y, Yamashita K, Hayashi S, et al.: Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13: 675–685, 2011
40. Zhang WR, Hayashi T, Iwai M, et al.: Time dependent amelioration against ischemic brain damage by glial cell line-derived neurotrophic factor after transient middle cerebral artery occlusion in rat. Brain Res 903: 253–256, 2001
41. Luk YO, WY Chen, WJ Wong, et al.: Treatment of focal cerebral ischemia with liposomal nerve growth factor. Drug Deliv 11: 319–324, 2004
42. Zhu W, S Cheng, G Xu, et al.: Intranasal nerve growth factor enhances striatal neurogenesis in adult rats with focal cerebral ischemia. Drug Deliv 18: 338–343, 2011
43. Jiang Y, Wei N, Zhu J, et al.: Effects of brain-derived neurotrophic factor on local inflammation in experimental stroke of rat. Mediators Inflamm 2010: 372423. 2010;
44. Schäbitz WR, Steigleder T, Cooper-Kuhn CM, et al.: Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke 38: 2165–2172, 2007
45. Jin K, Zhu Y, Sun Y, Mao XO, Xie L, Greenberg DA: Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 99: 11946–11950, 2002
46. Sun Y, Jin K, Xie L, et al.: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest 111: 1843–1851. 2003
47. Garcia JH, Liu KF, Ho KL: Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 26: 636–642, 1995
48. Chen J, Li Y, Katakowski M, et al.: Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73: 778–786, 2003
49. Ogawa A, Izumi S, Katayama Y, et al.: The Joint Committee on Guidelines for the Management of Stroke: Japanese Guidelines for the Management of Stroke 2015 (in Japanese). Tokyo, Kyowa Kikaku, 2015, p66